Status:
COMPLETED
Stereotactic Radiation Therapy in Treating Patients With Brain Metastases
Lead Sponsor:
Ohio State University Comprehensive Cancer Center
Conditions:
Metastatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This phase II trial is study how well stereotactic radiatio...
Detailed Description
OBJECTIVES: Primary * To determine the neurological death rate following the initiation of conformal stereotactic radiotherapy in patients with 1-3 brain metastases. Secondary * To determine the o...
Eligibility Criteria
Inclusion
- Histology-confirmed cancer with 1 to 3 symptomatic brain metastases imaged by MRI/CT scans.
- Have cancer not originating in central nervous system (CNS)
- Karnofsky score of at least 60
- Given written consent
- At least 18 years of age
Exclusion
- Prior whole brain radiotherapy or prior focal radiotherapy of the metastasis/es considered for this trial.
- Certain radiosensitive primary tumors such as small cell lung cancer, germ cell tumors, lymphoma, leukemia or multiple myeloma.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00983359
Start Date
April 1 2007
End Date
August 1 2012
Last Update
June 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210-1240